衞光生物(002880.SZ)擬捐助新型冠狀病毒防控物資支持抗擊疫情
格隆匯2月7日丨衞光生物(002880.SZ)公佈,公司高度關注新型冠狀病毒肺炎疫情進展,為切實履行上市公司社會責任、回饋社會,公司擬向深圳、武漢兩地的定點防控醫院,捐助臨牀急需的靜注人免疫球蛋白(pH4)、消毒劑(75%乙醇)、防護服等新型冠狀病毒防控物資,捐助物資金額在人民幣200萬元以內,具體金額以實際捐助金額為準,並授權公司經營管理層辦理具體捐助事宜。
公司此次對外捐贈是為了支持抗擊新型冠狀病毒肺炎疫情,積極承擔社會責任。此次對外捐助物資主要為公司自產藥品及用自有資金採購的消毒劑、防護服等防控物資,對公司當期及未來經營業績不構成重大影響,不存在損害公司和全體股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.